Review the side-effects of Sitagliptin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

The FDA has approved a fixed-dose combination tablet consisting of sitagliptin and simvastatin, two drugs previously approved for type 2 diabetes and hypercholesterolemia. The new drug will be ...

SITAGLIPTIN MYLAN 100 mg is a round shaped, biconvex beige film coated tablets debossed with “L” on one side and plain on other side. (AUST R 384802) Sponsor ...

A giant, international trial involving more than 14,000 patients found that the dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin, marketed by Merck as Januvia, does not cause adverse ...

(HealthDay)—Sitagliptin has a neutral effect on cardiovascular risk among older patients with type 2 diabetes, according to a study published online Jan. 5 in Diabetes Care.

Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats. Experimental Biology and Medicine , 2011; 236 (3): 309-314 DOI: 10.1258/ebm.2010.010161 Cite This Page : ...

UPDATED // The TECOS study showed sitagliptin was not associated with any signal of cardiovascular risk and, importantly, absolutely no increase in the risk of heart failure, a signal that has ...

Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular diseas ...